Incyte's Opzelura cream has become the first medical treatment approved to re-pigment the skin of people with vitiligo in the US, adding to its current use in atopic dermatitis. The FDA's decision to ...

People with vitiligo often need to use many medicines every day to help regain pigment in their skin and reduce other side effects. Some people may use light therapy, pills, or surgery to help reverse ...

If you have a certain kind of skin condition, your doctor may prescribe Opzelura for you. Opzelura is a prescription drug used in certain adults and children to treat: mild to moderate eczema ...

As Incyte Corporation’s recently-minted Opzelura gets off to the races in eczema, the drug has run up against a setback in another dermatology indication. The FDA has delayed its decision on Incyte’s ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Incyte’s closely watched Opzelura cream launch for atopic dermatitis just hit a road bump. The “unexpected slowdown” happened as the shift from free to paid Opzelura caused a delay in filling those ...

New York, USA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- OPZELURA Continues to Revolutionize the Dermatology Market with Strong Market Uptake | DelveInsight OPZELURA (ruxolitinib cream) has shown strong ...

Findings showed 56.5% of patients receiving ruxolitinib cream 1.5% achieved IGA-TS compared with 10.8% of those receiving placebo. The Food and Drug Administration (FDA) has approved Opzelura ® ...

Transparency is our policy. Learn how it impacts everything we do Investing Terms and Definitions ...